Optimizing CML Management: Shared Decision Making and Enhancing the Patient Experience - Episode 1

Understanding CML: Your Journey from Diagnosis to Treatment

July 31, 2024
Jorge E. Cortes, MD

,
Joannie Clements

,
Claire Saxton

A panel of experts on introduce a discussion on chronic myeloid leukemia (CML) with an overview of the disease, focusing on its subtypes and characteristics.

Now Viewing
EP. 1: Understanding CML: Your Journey from Diagnosis to Treatment
EP. 2: Navigating CML: Tools to Empower Patients and Caregivers
EP. 3: Empowering CML Caregivers: Strategies and Support Systems
EP. 4: Starting CML Treatment: Collaborative Choices for Better Outcomes
EP. 5: Open Dialogue in CML Care: Setting Expectations, Managing Side Effects, and Optimizing Patient Quality of Life
EP. 6: When CML Therapy Shifts: Collaborative Approaches to Treatment Changes
EP. 7: CML Treatment: Scenarios that Necessitate Switching Therapy
EP. 8: Ensuring Informed CML Care from Diagnosis Onward
EP. 9: Advancing CML Management Towards an Ideal Patient Journey

This program was made possible with support from Novartis Pharmaceuticals.

Video content above is prompted by the following questions:

  • Please provide some background on CML. What are the different subtypes of CML and how do they differ in terms of presentation and management?
  • Can you explain the typical prognosis and disease course for someone diagnosed with CML? How do you educate newly diagnosed patients on what to expect?

Related Content:

Optimizing CML Management: Shared Decision Making and Enhancing the Patient ExperienceGeorgia Cancer Center at Augusta UniversityBlood CancersCURE Expert Connections
Ryoncil Receives FDA Approval for Children With GVHD
Pregnancy-Associated Hematological Malignancies Linked With Complications
Identifying Cardiovascular Disease Risk in Cancer Survivors